STAG2 loss in Ewing sarcoma alters enhancer-promoter contacts dependent and independent of EWS::FLI1
RNA-seq (gene expression) · human · 32 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Ewing sarcomaThis series is part of our curated briefing on it.
- Samples
- 32 samples: 25 distinct titles, 3 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE267222_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1110268 and SRA study SRP507042. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 32 sample titles: 25 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8262540 A673 WT Rep1 Exp1
- GSM8262541 A673 WT Rep2 Exp1
- GSM8262542 A673 WT-Parental Exp1
- GSM8262543 A673 STAG2ko clone1 Exp1
- GSM8262544 A673 STAG2ko clone4 Exp1
- GSM8262545 A673 WT Rep1 Exp2
- GSM8262546 A673 WT Rep2 Exp2
- GSM8262547 A673 WT-Parental Exp2
- GSM8262548 A673 STAG2ko clone3 Exp2
- GSM8262549 A673 STAG2ko clone2 Exp2
- GSM8262550 A673 STAG2ko clone5 Exp2
- GSM8262551 A673 EZH2ko clone1 Exp2
- GSM8262552 A673 EZH2ko clone2 Exp2
- GSM8262553 A673 EZH2ko clone3 Exp2
- GSM8262554 A673SUZ12ko clone1 Exp2
- GSM8262555 A673 SUZ12ko clone2 Exp2
- GSM8262556 A673 SUZ12ko clone3 Exp2
- GSM8262557 A673 WT Rep1 Exp3
- GSM8262558 A673 WT-Parental Exp3
- GSM8262559 A673 STAG1ko clone1 Exp3
- GSM8262560 A673 STAG1ko clone2 Exp3
- GSM8262561 A673 STAG1ko clone3 Exp3
- GSM8262562 A673 WT Rep1 Exp4
- GSM8262563 A673 WT Rep2 Exp4
- GSM8262564 A673 WT Rep3 Exp4
- GSM8262565 A673 siSTAG2 Rep1 Exp4
- GSM8262566 A673 siSTAG2 Rep2Exp4
- GSM8262567 A673 siSTAG2 Rep3 Exp4
- GSM8262568 A4573 WT
- GSM8262569 A4573 STAG2 KI
- GSM8262570 SKNMC WT
- GSM8262571 SKNMC STAG2ko
- GSE267223 STAG2 loss in Ewing sarcoma alters enhancer-promoter contacts dependent and independent of EWS::FLI1 52 samples same disease briefing · shares stag2, fli1, ews, enhancer-promoter, independent, dependent, contacts, sarcoma
- GSE267220 STAG2 loss in Ewing sarcoma alters enhancer-promoter contacts dependent and independent of EWS::FLI1 4 samples same disease briefing · shares stag2, fli1, ews, enhancer-promoter, independent, dependent, contacts, sarcoma
- GSE211743 KDM6A and B-mediated transcriptional activation of EWSR1-FLI1 targets coordinates demethylase dependent and independent mechanisms in Ewing sarcoma 99 samples same disease briefing · shares fli1, ews, independent, dependent, sarcoma
- GSE314154 STAG2 loss amplifies EWS-FLI1-driven microsatellite enhancer activity promoting Ewing's sarcoma aggressiveness [RNA-Seq] 20 samples same disease briefing · shares stag2, fli1, ews, sarcoma
- GSE229906 Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling 45 samples same disease briefing · shares fli1, ews, sarcoma
- GSE322664 Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial 41 samples same disease briefing · shares fli1, ews, sarcoma
- GSE272957 EWSR1/FLI1 Expression in Human Mesenchymal Stem Cells derived from Experimental Teratomas Leads to Ewing´s Sarcoma Tumorigenesis [RNA-seq] 16 samples same disease briefing · shares fli1, ews, sarcoma
- GSE231453 RNA-Seq of Ewing sarcoma shA673-1c cells after knockdown of EWS::FLI1 12 samples same disease briefing · shares fli1, ews, sarcoma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.